Trends in New Use of Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001-2022
Arthritis Rheumatol. 2024 Oct 22. doi: 10.1002/art.43041. Online ahead of print. ABSTRACT OBJECTIVE: To describe recent trends in DMARD use for children with juvenile idiopathic …